MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$10,882K
Net Income
$8,780K
Net Profit Margin
80.68%
EPS
$0.72
Unit: Thousand (K) dollars
Revenue Breakdown
Finance receivable interest inco...
Other
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Total revenues
10,882
10,052
11,832
10,418
Provision (benefit) for credit losses
-931
761
-1,465
1,385
Loss on impairment of intangibles assets
209
0
-
-
Loss on disposal of inventory
314
-
-
-
Interest expense
1,179
1,155
1,130
1,139
Pharmaceutical manufacturing, research and development expense
147
645
758
585
Change in fair value of acquisition-related contingent consideration
0
0
-
-
Depreciation and amortization expense
2
19
19
234
General and administrative expense
3,286
2,843
3,277
2,993
Income from operations
6,676
4,629
8,113
4,082
Unrealized net (loss) gain on marketable investments
-
-
-
-6
Unrealized net gains on warrants
2,640
347
-424
47
Net gain on exercise and cancellation of warrants
0
0
-
-
Loss on sale of assets
0
0
-82
-
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax
1,601
-
-
-
Net loss on marketable investments
-246
37
-105
-
Realized gain on early payment of finance receivable
0
0
1,729
-
Gain (loss) on revaluation of finance receivables
0
0
-3,727
-
Realized and unrealized foreign currency transaction gains (losses)
25
-451
313
251
Income before income tax expense
10,696
4,562
5,817
4,374
Income tax expense
1,916
1,026
1,278
906
Net income
8,780
3,536
4,539
3,468
Basic EPS
0.72
0.29
0.37
0.28
Diluted EPS
0.72
0.29
0.37
0.28
Basic Average Shares
12,117,000
12,208,000
12,229,000
12,318,000
Diluted Average Shares
12,117,000
12,208,000
12,240,000
12,408,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Finance receivable
interest income,...
$10,822K
(13.94%↑ Y/Y)
Other
$60K
(-79.45%↓ Y/Y)
Total revenues
$10,882K
(4.45%↑ Y/Y)
Provision (benefit) for
credit losses
-$931K
(-167.22%↓ Y/Y)
Income from operations
$6,676K
(63.55%↑ Y/Y)
Unrealized net gains on
warrants
$2,640K
(5517.02%↑ Y/Y)
Discontinued operation, gain
(loss) on disposal of...
$1,601K
General and
administrative expense
$3,286K
(9.79%↑ Y/Y)
Interest expense
$1,179K
(3.51%↑ Y/Y)
Realized and unrealized
foreign currency...
$25K
(-90.04%↓ Y/Y)
Loss on disposal of
inventory
$314K
Loss on impairment of
intangibles assets
$209K
Pharmaceutical manufacturing,
research and development...
$147K
(-74.87%↓ Y/Y)
Depreciation and
amortization expense
$2K
(-99.15%↓ Y/Y)
Income before income
tax expense
$10,696K
(144.54%↑ Y/Y)
Net loss on
marketable investments
-$246K
Net income
$8,780K
(153.17%↑ Y/Y)
Income tax expense
$1,916K
(111.48%↑ Y/Y)
Buy us a coffee
SWK Holdings Corp (SWKH)
SWK Holdings Corp (SWKH)